Evaluation of Efficacy of Antibacterial Activity of Licorice, Clove, and Chlorohexidine Mouthwashes on Salivary Streptococcus Mutans in a Group of Egyptian Children.
1 other identifier
interventional
54
1 country
1
Brief Summary
A randomized controlled trial that compares the antibacterial effectiveness of three mouthwashes-licorice, clove, and chlorhexidine-in Egyptian children aged 7-12 years. The main focus is Streptococcus mutans, one of the main bacteria associated with dental caries. The saliva samples will be collected from the children and the amount of S. mutans will be measured before and after using the assigned mouthwash. The children will be randomly divided into groups, with each group receiving one of the three mouthwashes. The bacterial counts will then be compared to determine which mouthwash is most effective at reducing salivary S. mutans. The research question is whether natural mouthwashes made from licorice or clove reduce the bacteria that cause cavities as effectively as chlorhexidine in children? The study could help determine whether licorice and clove are effective natural alternatives or adjuncts to chlorhexidine, particularly considering that chlorhexidine can have undesirable effects with prolonged use. Overall aim: Compare and evaluate the antibacterial efficacy of the three mouthwashes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 6, 2025
CompletedFirst Submitted
Initial submission to the registry
September 7, 2026
CompletedFirst Posted
Study publicly available on registry
September 18, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2027
September 18, 2026
September 1, 2026
1.2 years
September 7, 2026
September 14, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction of dental caries incidence in high-caries index pediatric patients using International Caries Detection and Assessment System.
Baseline(Day 1), 2 weeks postoperative, then 3 months postoperative.
Secondary Outcomes (3)
The reduction in Streptococcus mutans count following the use of licorice and clove mouthwashes in Egyptian pediatric patients aged from 7 to 12.
Baseline(Day 1), 2 weeks postoperative, then 3 months postoperative.
Patient reported satisfaction, regarding the taste using a questionnaire.
Through study completion, an average of 3 months.
Adverse events related to the use of the licorice and clove mouthwashes, regarding oral irritation and allergies using a questionnaire.
Through study completion, an average of 3 months.
Study Arms (3)
Chlorohexidine Mouthwash
ACTIVE COMPARATORClove mouthwash
EXPERIMENTALLicorice mouthwash
EXPERIMENTALInterventions
The interventions will consist of three different mouthwashes: licorice mouthwash, clove mouthwash, and 0.2% chlorhexidine mouthwash. Each participant will use the mouthwash assigned to their study group according to the standardized study protocol. The herbal mouthwashes will be prepared using standardized licorice and clove extracts at predetermined concentrations, while the chlorhexidine group will receive 0.2% chlorhexidine mouthwash as the positive control. All mouthwashes will be provided in identical, appropriately labeled containers to maintain blinding where applicable. The interventions will be distinguished by their active ingredient and concentration, while the method, frequency, duration of use, and volume administered will be standardized across all groups.
Eligibility Criteria
You may qualify if:
- Pediatric patients with high caries index based on CAMBRA.
- Frankl scale 3 and 4 (cooperative).
You may not qualify if:
- Patients with teeth showing signs of infection (abscess or fistula)
- Patients with mucositis (can't be given alcohol containing mouthwashes)
- Hypertensive patients.
- Allergic patients.
- Special health care patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The British university in Egypt
Cairo, Cairo Governorate, Egypt
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Primary investigator
Study Record Dates
First Submitted
September 7, 2026
First Posted
September 18, 2026
Study Start
October 6, 2025
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
June 1, 2027
Last Updated
September 18, 2026
Record last verified: 2026-09